Strong ULT Freezer Orders for First Month of 2021 for Reflect Scientific Inc.
Reflect Scientific, Inc. (RSCF) announced strong orders of $231K for its Cryometrix ultra-low temperature freezers, indicating robust demand in January 2021. CEO Kim Boyce noted that these freezers are becoming vital for the cold chain management in pharmaceuticals. The Cryometrix series employs patented liquid nitrogen cooling technology, offering superior reliability and performance compared to traditional freezers, with capacities ranging from 120 to 950 liters.
- Secured $231K in new orders for Cryometrix freezers.
- Growing demand for Cryometrix freezers indicates strong market position.
- Patented liquid nitrogen cooling technology enhances product reliability.
- None.
OREM, Utah, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces continued strong orders with an additional
Mr. Kim Boyce, CEO of Reflect Scientific Inc., commented, “We have had a great first month of 2021 for freezer orders, and we expect this trend to continue. The Cryometrix freezers are becoming an integral part of the cold chain management for pharmaceutical companies.”
The Cryometrix line of ultra-low temperature freezers uses patented liquid nitrogen cooling technology to achieve cooling rates and system reliability far exceeding current freezer technologies. The Cryometrix ultra-low temperature freezers are available from a 120 liter chest to a front opening unit with 950 liters of capacity.
About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit www.reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”
Contact
Thomas Tait
801-607-1039
investor_relations@reflectscientific.com
FAQ
What are the recent developments for Reflect Scientific (RSCF)?
How does Cryometrix technology benefit pharmaceutical companies?
What is the capacity range of Cryometrix ultra-low temperature freezers?
What does the future look like for Reflect Scientific (RSCF)?
